Pharmaceutical preparations and substances; chemicals for pharmaceutical use; pharmaceuticals and pharmaceutical preparations being nanoparticles; pharmaceuticals and pharmaceutical preparations containing siRNA; pharmaceuticals and pharmaceutical preparations containing RNA; pharmaceuticals and pharmaceutical preparations containing shRNA; pharmaceuticals and pharmaceutical preparations containing mRNA; pharmaceuticals and pharmaceutical preparations containing DNA; drug delivery agents being made from lipids, liposomes or peptides; pharmaceuticals and pharmaceutical preparations containing lipids, liposomes or peptides; drug delivery agents; drug delivery agents that facilitate the delivery of pharmaceuticals and pharmaceutical preparations; intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; pharmaceutical and drug delivery agents for use in relation to the delivery of siRNA, shRNA, mRNA, RNA, DNA or other genetic material; preparations for detecting genetic predispositions for medical purposes; pharmaceuticals and pharmaceutical preparations for use in gene therapy; drug delivery agents for use in gene therapy; drug delivery agents being nanoparticles; pharmaceutical and natural remedies; medical preparations; biochemical preparation for medical purposes; biological preparations for medical purposes; reagents for medical use; reagents for use in medical genetic testing; anti-cancer preparations; anti-cancer drugs; compounds for treating cancer; biopharmaceuticals for the treatment of cancer; anti-cancer preparations of chemical origin; anti-cancer preparations of plant origin; anti-cancer preparations of microbial origin; pharmaceutical preparations for the treatment of cancer; pharmaceutical products for the treatment of cancer; biological preparations for the treatment of cancer; anticancer preparations from hormones and antagonists; pharmaceutical preparations and substances for the prevention of cancer; chemotherapeutics; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for the treatment and prevention of tumours.
ABANDONED SECTION 36
on 23 Mar 2021
LIPTIDE
NANOGENICS LIMITED
1907249 · 03 Jul 2018
005
Class 005
Pharmaceutical Products
Pharmaceutical preparations and substances; chemicals for pharmaceutical use; pharmaceuticals and pharmaceutical preparations being nanoparticles; pharmaceuticals and pharmaceutical preparations containing siRNA; pharmaceuticals and pharmaceutical preparations containing RNA; pharmaceuticals and pharmaceutical preparations containing shRNA; pharmaceuticals and pharmaceutical preparations containing mRNA; pharmaceuticals and pharmaceutical preparations containing DNA; drug delivery agents being made from lipids, liposomes or peptides; pharmaceuticals and pharmaceutical preparations containing lipids, liposomes or peptides; drug delivery agents; drug delivery agents that facilitate the delivery of pharmaceuticals and pharmaceutical preparations; intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; pharmaceutical and drug delivery agents for use in relation to the delivery of siRNA, shRNA, mRNA, RNA, DNA or other genetic material; preparations for detecting genetic predispositions for medical purposes; pharmaceuticals and pharmaceutical preparations for use in gene therapy; drug delivery agents for use in gene therapy; drug delivery agents being nanoparticles; pharmaceutical and natural remedies; medical preparations; biochemical preparation for medical purposes; biological preparations for medical purposes; reagents for medical use; reagents for use in medical genetic testing; anti-cancer preparations; anti-cancer drugs; compounds for treating cancer; biopharmaceuticals for the treatment of cancer; anti-cancer preparations of chemical origin; anti-cancer preparations of plant origin; anti-cancer preparations of microbial origin; pharmaceutical preparations for the treatment of cancer; pharmaceutical products for the treatment of cancer; biological preparations for the treatment of cancer; anticancer preparations from hormones and antagonists; pharmaceutical preparations and substances for the prevention of cancer; chemotherapeutics; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for the treatment and prevention of tumours.
Pharmaceutical preparations and substances; chemicals for pharmaceutic...
